|
Trial no.:
|
PACTR201406000609270 |
Date of Registration:
|
07/08/2013 |
|
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
| TRIAL DESCRIPTION |
|
Public title
|
Polymorphism of metabolisation and clinical implications |
| Official scientific title |
Profile of Isoniazid Acetylation Phenotype in Rwandan healthy subjects and Tuberculosis patients |
|
Brief summary describing the background
and objectives of the trial
|
Numerous studies have demonstrated how an individual's genetic profile may be used for adjusting drug dosage and choosing a medication with minimal side effects. This study is to picture on the normal profile of acetylator phenotype, the effect of Tuberculosis (TB) on the profile, and the impact of the profile on the early clinical responses following treatment with the first line drugs. |
| Type of trial |
CCT |
| Acronym (If the trial has an acronym then please provide) |
|
| Disease(s) or condition(s) being studied |
Infections and Infestations |
| Sub-Disease(s) or condition(s) being studied |
Tuberculosis |
| Purpose of the trial |
Treatment: Other |
| Anticipated trial start date |
02/01/2012 |
| Actual trial start date |
01/03/2012 |
| Anticipated date of last follow up |
29/08/2014 |
| Actual Last follow-up date |
|
| Anticipated target sample size (number of participants) |
200 |
| Actual target sample size (number of participants) |
|
| Recruitment status |
Recruiting |
| Publication URL |
|
|